According to Spiegel, the pharmaceutical industry is fiercely resisting the federal government’s planned cuts. In response to the reform plans, several companies have announced they will reduce or completely halt their investments in Germany.
Politicians have reacted with outrage to the pharma lobby’s behavior. They accuse the industry of using the investment freeze to put pressure on policymakers. Whether the government will cave in the face of this opposition remains unclear.
Source: www.spiegel.de
